Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
2.020
-0.010 (-0.49%)
Sep 26, 2025, 3:00 PM CST
Kangmei Pharmaceutical Market Cap
Kangmei Pharmaceutical has a market cap or net worth of 27.93 billion as of September 26, 2025. Its market cap has increased by 10.71% in one year.
Market Cap
27.93B
Enterprise Value
27.20B
Revenue
5.29B
Ranking
n/a
PE Ratio
2,875.46
Stock Price
2.02
Market Cap Chart
Since March 19, 2001, Kangmei Pharmaceutical's market cap has increased from 2.58B to 27.93B, an increase of 983.34%. That is a compound annual growth rate of 10.20%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 26, 2025 | 27.93B | -13.89% |
Dec 31, 2024 | 32.44B | 25.81% |
Dec 29, 2023 | 25.79B | -15.45% |
Dec 30, 2022 | 30.50B | -28.80% |
Dec 31, 2021 | 42.84B | 221.38% |
Dec 31, 2020 | 13.33B | -28.15% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 481.77B |
WuXi AppTec | 299.68B |
Shenzhen Mindray Bio-Medical Electronics | 296.30B |
Sichuan Biokin Pharmaceutical | 149.53B |
Zhangzhou Pientzehuang Pharmaceutical., | 119.01B |
Shanghai United Imaging Healthcare | 118.35B |
Aier Eye Hospital Group | 114.80B |
Yunnan Baiyao Group Co.,Ltd | 102.20B |